Kwikril-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides additional analgesic and antipyretic benefits through central inhibition of prostaglandin synthesis, complementing the action of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory exudates, promoting the resolution of inflammation and reducing swelling and pain. This synergistic combination is indicated for the management of acute and chronic musculoskeletal conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries such as sprains and strains. Kwikril-SP is effective in alleviating moderate to severe pain associated with inflammation and tissue injury, enhancing patient comfort and mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risks or bleeding disorders. The dosage regimen should be tailored to individual patient needs, ensuring optimal therapeutic outcomes while minimizing adverse effects.

Dosage & How to Use